Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway
Open accessThe DOI matches its Crossref record; 116 of the 119 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. During the past decade, novel pathogenic mechanisms of IPF have been elucidated that have shifted the concept of IPF from an inflammatory-driven to an epithelial-driven disease. Dysregulated repair responses induced by recurrent epithelial cell damage and excessive extracellular matrix accumulation result in pulmonary fibrosis. Although there is currently no curative therapy for IPF, two medications, pirfenidone and nintedanib, have been introduced based on understanding the pathogenesis of the disease. In this review, we discuss advances in understanding IPF pathogenesis, highlighting epithelial–mesenchymal transition (EMT), the ubiquitin-proteasome system, and endothelial cells. TGF-β is a central regulator involved in EMT and pulmonary fibrosis. HECT-, RING finger-, and U-box-type E3 ubiquitin ligases regulate TGF-β-Smad pathway-mediated EMT via the ubiquitin-proteasome pathway. p27 degradation mediated by the SCF-type E3 ligase, Skp2, contributes to the progression of pulmonary fibrosis by promotion of either mesenchymal fibroblast proliferation, EMT, or both. In addition to fibroblasts as key effector cells in myofibroblast differentiation and extracellular matrix deposition, endothelial cells also play a role in the processes of IPF. Endothelial cells can transform into myofibroblasts; therefore, endothelial–mesenchymal transition can be another source of myofibroblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ND L02-s0201 (formerly BMS 986263) is a lipid nanoparticle containing siRNA which inhibits HSP47, which is a collagen specific chaperone that ensures proper collagen formation [190].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [190]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation
Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539 · cited 3×
“Regarding interleukins, levels of the proinflammatory cytokine, IL-18, are elevated in serum, airway epithelium, and alveolar macrophages of patients with IPF [32].”
BackgroundInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005 · cited 7×
“No model can completely reproduce all the physiological and histopathological features of human pulmonary fibrosis (Figure 1) [23,46,49], although the mouse models can help to elucidate the mechanism of this complex disease.”
BackgroundMethodInfluentialLovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935 · cited 5×
“STUB1 targets Smad3 [92] and NOX4 for degradation to negatively regulate TGF-β-signaling [86].”
BackgroundInfluentialGlobal incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Michiels, C. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10333 · Cited by 773
Spectrum of fibrotic lung diseases
Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679
Duncan, M. R., Frazier, K. S., Abramson, S., Williams, S., Klapper, H., Huang, X., & Grotendorst, G. R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1774 · Cited by 631
HECT and RING finger families of E3 ubiquitin ligases at a glance
Metzger, M. B., Hristova, V. A., & Weissman, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091777 · Cited by 630
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Metzger, M. B., Pruneda, J. N., Klevit, R. E., & Weissman, A. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.026 · Cited by 611
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
Idiopathic pulmonary fibrosis: pathogenesis and management
Sgalla, G., Iovene, B., Calvello, M., Ori, M., Varone, F., & Richeldi, L. (2018) · Respiratory Research · doi:10.1186/s12931-018-0730-2 · Cited by 573
Increased Prevalence of Gastroesophageal Reflux in Patients with Idiopathic Pulmonary Fibrosis
TOBIN, R. W., POPE, C. E., PELLEGRINI, C. A., EMOND, M. J., SILLERY, J., & RAGHU, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9804105 · Cited by 570
Khalil, N., O'Connor, R. N., Unruh, H. W., Warren, P. W., Flanders, K. C., Kemp, A., Bereznay, O. H., & Greenberg, A. H. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.2.155 · Cited by 521
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Della Latta, V., Cecchettini, A., Del Ry, S., & Morales, M. A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.012 · Cited by 514
Natsuizaka, M., Chiba, H., Kuronuma, K., Otsuka, M., Kudo, K., Mori, M., Bando, M., Sugiyama, Y., & Takahashi, H. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0566oc · Cited by 502
Selman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 454
Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Hashimoto, N., Phan, S. H., Imaizumi, K., Matsuo, M., Nakashima, H., Kawabe, T., Shimokata, K., & Hasegawa, Y. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0031oc · Cited by 451
Regulation of TGF-β Family Signaling by Inhibitory Smads
Miyazawa, K., & Miyazono, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022095 · Cited by 439 · cited 1×
“They are inhibitory Smads (I-Smad) and Smadcofactors [70].”
BackgroundNew cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Fernandez, I. E., & Eickelberg, O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61144-1 · Cited by 437
Jenkins, R. G., Moore, B. B., Chambers, R. C., Eickelberg, O., Königshoff, M., Kolb, M., Laurent, G. J., Nanthakumar, C. B., Olman, M. A., Pardo, A., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0096st · Cited by 435
Animal Models of Fibrotic Lung Disease
B. Moore, B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 412
The pathogenesis of pulmonary fibrosis: a moving target
Wuyts, W. A., Agostini, C., Antoniou, K. M., Bouros, D., Chambers, R. C., Cottin, V., Egan, J. J., Lambrecht, B. N., Lories, R., Parfrey, H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00073012 · Cited by 356
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
MIYAZONO, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.314 · Cited by 337
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Hewlett, J. C., Kropski, J. A., & Blackwell, T. S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.021 · Cited by 321
Allen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., Guillen-Guio, B., Ma, S.-F., Okamoto, T., John, A. E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30387-9 · Cited by 297 · cited 1×
“Genome-wide association studies have identified several genetic variants associated with the development of IPF that can be considered IPF susceptibility genes, such as telomerase reverse transcriptase (TERT), desmoplakin (DSP), and A-kinase anchoring protein 13 (AKAP13) [44].”
BackgroundCellular interactions in the pathogenesis of interstitial lung diseases
Bagnato, G., & Harari, S. (2015) · European Respiratory Review · doi:10.1183/09059180.00003214 · Cited by 277
U-box proteins as a new family of ubiquitin ligases
Hatakeyama, S., & Nakayama, K.-I. I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00245-6 · Cited by 264
Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Salton, F., Volpe, M., & Confalonieri, M. (2019) · Medicina · doi:10.3390/medicina55040083 · Cited by 261
Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis
Lasky, J. A., Ortiz, L. A., Tonthat, B., Hoyle, G. W., Corti, M., Athas, G., Lungarella, G., Brody, A., & Friedman, M. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.2.l365 · Cited by 247
Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis
Fell, C. D., Martinez, F. J., Liu, L. X., Murray, S., Han, M. K., Kazerooni, E. A., Gross, B. H., Myers, J., Travis, W. D., Colby, T. V., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0959oc · Cited by 243
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
Lu, Z., & Hunter, T. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 224
Fukasawa, H., Yamamoto, T., Togawa, A., Ohashi, N., Fujigaki, Y., Oda, T., Uchida, C., Kitagawa, K., Hattori, T., Suzuki, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400035101 · Cited by 215
Self-citationHoshino, T., Okamoto, M., Sakazaki, Y., Kato, S., Young, H. A., & Aizawa, H. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0182oc · Cited by 163
IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis
Huang, M., Sharma, S. P., Zhu, L. X., Keane, M. P., Luo, J., Zhang, L., Burdick, M. D., Lin, Y. Q., Dohadwala, M., Gardner, B. K., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14685 · Cited by 152
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Zank, D. C., Bueno, M., Mora, A. L., & Rojas, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00010 · Cited by 150
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Santana, A., Saxena, B., Noble, N. A., Gold, L. I., & Marshall, B. C. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7541221 · Cited by 135
Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts
Renzoni, E. A., Abraham, D. J., Howat, S., Shi-Wen, X., Sestini, P., Bou-Gharios, G., Wells, A. U., Veeraraghavan, S., Nicholson, A. G., Denton, C. P., et al. (2004) · Respiratory Research · doi:10.1186/1465-9921-5-24 · Cited by 127
Spectrum of Fibrotic Lung Diseases
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2031135 · Cited by 126
Ubiquitin‐mediated control of oncogene and tumor suppressor gene products
Kitagawa, K., Kotake, Y., & Kitagawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01196.x · Cited by 123
Self-citationAge-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., López-Otín, C., & Pardo, A. (2016) · European Respiratory Journal · doi:10.1183/13993003.00398-2016 · Cited by 122
NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
Lasithiotaki, I., Giannarakis, I., Tsitoura, E., Samara, K. D., Margaritopoulos, G. A., Choulaki, C., Vasarmidi, E., Tzanakis, N., Voloudaki, A., Sidiropoulos, P., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00564-2015 · Cited by 120
Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease
Kimura, T., Kawabe, H., Jiang, C., Zhang, W., Xiang, Y.-Y., Lu, C., Salter, M. W., Brose, N., Lu, W.-Y., & Rotin, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010334108 · Cited by 113
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Tomčík, M., Zerr, P., Pitkowski, J., Palumbo‐Zerr, K., Avouac, J., Distler, O., Bečvář, R., Šenolt, L., Schett, G. A., & Distler, J. H. W. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203095 · Cited by 111
FBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping
Wang, L., Chen, R., Li, G., Wang, Z., Liu, J., Liang, Y., & Liu, J.-P. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.004 · Cited by 109
Duerr, J., Leitz, D. H. W., Szczygiel, M., Dvornikov, D., Fraumann, S. G., Kreutz, C., Zadora, P. K., Seyhan Agircan, A., Konietzke, P., Engelmann, T. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15743-6 · Cited by 107
Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis
Kang, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122527 · Cited by 106
Sakai, S., Ohhata, T., Kitagawa, K., Uchida, C., Aoshima, T., Niida, H., Suzuki, T., Inoue, Y., Miyazawa, K., & Kitagawa, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3210 · Cited by 104
Self-citationTsubouchi, K., Araya, J., Minagawa, S., Hara, H., Ichikawa, A., Saito, N., Kadota, T., Sato, N., Yoshida, M., Kurita, Y., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1328348 · Cited by 103
Recent advances in SCF ubiquitin ligase complex: Clinical implications
Zheng, N., Zhou, Q., Wang, Z. P., & Wei, W. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.05.001 · Cited by 102
Enhanced Expression of Interleukin-18 and its Receptor in Idiopathic Pulmonary Fibrosis
Kitasato, Y., Hoshino, T., Okamoto, M., Kato, S., Koda, Y., Nagata, N., Kinoshita, M., Koga, H., Yoon, D., Asao, H., et al. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0306oc · Cited by 101
Idiopathic Pulmonary Fibrosis Related to Endothelial Injury and Antiendothelial Cell Antibodies
MAGRO, C. M. J., Waldman, W. J., Knight, D. A., Allen, J. N., Nádasdy, T., Frambach, G. E., Ross, P., & Marsh, C. B. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.026 · Cited by 100
Hsp90 regulation of fibroblast activation in pulmonary fibrosis
Sontake, V., Wang, Y., Kasam, R. K., Sinner, D., Reddy, G. B., Naren, A. P., McCormack, F. X., White, E. S., Jegga, A. G., & Madala, S. K. (2017) · JCI Insight · doi:10.1172/jci.insight.91454 · Cited by 100
Huang, S. K., Scruggs, A. M., McEachin, R. C., White, E. S., & Peters-Golden, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107055 · Cited by 93
A Role for Dendritic Cells in Bleomycin-induced Pulmonary Fibrosis in Mice?
Bantsimba-Malanda, C., Marchal-Sommé, J., Goven, D., Freynet, O., Michel, L., Crestani, B., & Soler, P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1164oc · Cited by 86
Sibinska, Z., Tian, X., Korfei, M., Kojonazarov, B., Kolb, J. S., Klepetko, W., Kosanovic, D., Wygrecka, M., Ghofrani, H. A., Weissmann, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01941-2015 · Cited by 85
Endothelial Cells Recruit Macrophages and Contribute to a Fibrotic Milieu in Bleomycin Lung Injury
Leach, H., Chrobak, I., Han, R., & Trojanowska, M. E. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0152oc · Cited by 82
SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis
Elkouris, M., Kontaki, H., Stavropoulos, A., Antonoglou, A., Nikolaou, K. C., Samiotaki, M., Szantai, E., Saviolaki, D., Brown, P. J., Sideras, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.051 · Cited by 75
Nitric Oxide Mediates Bleomycin‐induced Angiogenesis and Pulmonary Fibrosis via Regulation of VEGF
Iyer, A. K. V., Ramesh, V., Castro, C. A., Kaushik, V., Kulkarni, Y. M., Wright, C. A., Venkatadri, R., Rojanasakul, Y., & Azad, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25192 · Cited by 67
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis
Kato, S., Inui, N., Hakamata, A., Suzuki, Y., Enomoto, N., Fujisawa, T., Nakamura, Y., Watanabe, H., & Suda, T. (2018) · Respiratory Research · doi:10.1186/s12931-018-0831-y · Cited by 64
Self-citationLong non‐coding RNAs and TGF‐β signaling in cancer
Papoutsoglou, P., & Moustakas, A. (2020) · Cancer Science · doi:10.1111/cas.14509 · Cited by 62
Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis
Almudéver, P., Milara, J., De Diego, A., Serrano-Mollar, A., Xaubet, A., Perez-Vizcaino, F., Cogolludo, A., & Cortijo, J. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203408 · Cited by 60
Transcriptional induction of Smurf2 ubiquitin ligase by TGF‐β
Ohashi, N., Yamamoto, T., Uchida, C., Togawa, A., Fukasawa, H., Fujigaki, Y., Suzuki, S., Kitagawa, K., Hattori, T., Oda, T., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.069 · Cited by 57
Self-citationShi, Y., Wang, X., Xu, Z., He, Y., Guo, C., He, L., Huan, C., Cai, C., Huang, J., Zhang, J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014976 · Cited by 55
Jäger, B., Seeliger, B., Terwolbeck, O., Warnecke, G., Welte, T., Müller, M., Bode, C., & Prasse, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642855 · Cited by 55
Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis
Bellaye, P.-S., Shimbori, C., Yanagihara, T., Carlson, D. A., Hughes, P., Upagupta, C., Sato, S., Wheildon, N., Haystead, T., Ask, K., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00386-2017 · Cited by 54
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Yanagihara, T., Sato, S., Upagupta, C., & Kolb, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0029-2019 · Cited by 53
Yoshimura, S., Nishimura, Y., Nishiuma, T., Yamashita, T., Kobayashi, K., & Yokoyama, M. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00894.x · Cited by 43
Update in Pulmonary Fibrosis 2018
Sgalla, G., Kulkarni, T., Antin-Ozerkis, D. E., Thannickal, V. J., & Richeldi, L. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0542up · Cited by 43
Biancatelli, R. M. L. C., Solopov, P. A., Gregory, B. W., & Catravas, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155286 · Cited by 43
Ji, J., Hou, J., Xia, Y., Xiang, Z., & Han, X. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166077 · Cited by 43
Watanabe-Takano, H., Takano, K., Hatano, M., Tokuhisa, T., & Endo, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127888 · Cited by 42
Dong, H., Luo, L., Zou, M., Huang, C., Wan, X., Hu, Y., Le, Y., Zhao, H., Li, W., Zou, F., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00489.2016 · Cited by 42
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Kitagawa, K., & Kitagawa, M. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151112122231 · Cited by 41
Self-citationTakabatake, N., Arao, T., Sata, M., Abe, S., Inoue, S., Shibata, Y., Takeishi, Y., & Kubota, I. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1663-1 · Cited by 39
MiR-411–3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling
Gao, X., Xu, H., Xu, D., Li, S., Wei, Z., Li, S., Cai, W., Mao, N., Jin, F., Li, Y., et al. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111878 · Cited by 37 · cited 1×
“miR411-3p [90] and miR-27a-3p [91] inhibit silica- and bleomycin-induced pulmonary fibrosis by suppressing Smurf2 expression.”
BackgroundSolopov, P. A., Biancatelli, R. M. L. C., Marinova, M. D., Dimitropoulou, C., & Catravas, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134740 · Cited by 35
Song, M. S., Peng, H., Guo, W., Luo, M., Wang, D., Chen, P., & Zhou, Y. (2019) · Respiration · doi:10.1159/000502099 · Cited by 32
Sakai, S., Miyajima, C., Uchida, C., Itoh, Y., Hayashi, H., & Inoue, Y. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151112122645 · Cited by 31
Self-citationMarinova, M. D., Solopov, P. A., Dimitropoulou, C., Biancatelli, R. M. L. C., & Catravas, J. D. (2020) · Experimental Lung Research · doi:10.1080/01902148.2020.1764148 · Cited by 31
Renal Damage in Obstructive Nephropathy Is Decreased in Skp2-Deficient Mice
Suzuki, S., Fukasawa, H., Kitagawa, K., Uchida, C., Hattori, T., Isobe, T., Oda, T., Misaki, T., Ohashi, N., Nakayama, K., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070279 · Cited by 24
Self-citationInhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis
Mikamo, M., Kitagawa, K., Sakai, S., Uchida, C., Ohhata, T., Nishimoto, K., Niida, H., Suzuki, S., Nakayama, K. I., Inui, N., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020474 · Cited by 21
Self-citationHeat Shock Protein 90 Regulates Subcellular Localization of Smads in Mv1Lu Cells
Lee, J., An, Y. S., Kim, M., Kim, Y., Lee, J. K., Hwang, C. S., Chung, E., Park, I., & Yi, J. Y. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25269 · Cited by 20
Roles of the Skp2/p27 axis in the progression of chronic nephropathy
Suzuki, S., Ohashi, N., & Kitagawa, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1232-x · Cited by 16
Self-citationSuzuki, S., Fukasawa, H., Misaki, T., Togawa, A., Ohashi, N., Kitagawa, K., Kotake, Y., Liu, N., Niida, H., Nakayama, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036249 · Cited by 16
Self-citationMUC5BPromoter Polymorphism and Pulmonary Fibrosis
Zhang, G., Liao, T., & Gao, W. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1105707 · Cited by 16
Heat shock protein: a hot topic in idiopathic pulmonary fibrosis
Bonniaud, P., Bellaye, P., Burgy, O., & Kolb, M. R. J. (2017) · European Respiratory Journal · doi:10.1183/13993003.02152-2016 · Cited by 15
TRB3 regulates pulmonary interstitial fibrosis through the MAPK signaling pathway.
Yu, W., Song, X., & Yaqiu, L. (2019) · PubMed Central · Cited by 15
Contemporary Concise Review 2019: Interstitial lung disease
George, P. M., & Wells, A. U. (2020) · Respirology · doi:10.1111/resp.13803 · Cited by 6
Cheng, W., Mi, L., Tang, J., & Yu, W. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9900 · Cited by 5
The effects of miR-27a-3p-mediated Smurf2 on bleomycin A5-induced pulmonary fibrosis in rats
Zhang, J., Zhang, J., & Zhang, Q. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.3.12 · Cited by 5
Yu, W., Mi, L., & Wang, F. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10863 · Cited by 4
Song, M., Peng, H., Guo, W., Luo, M., Wang, D., Chen, P., & Zhou, Y. (2019) · doi:10.1183/13993003.congress-2019.pa1285 · Cited by 2
Cited by
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Mei, Q., Liu, Z., Zuo, H., Yang, Z., & Qu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797292 · Cited by 360
TGF-β signaling: critical nexus of fibrogenesis and cancer
Giarratana, A. O., Prendergast, C. M., Salvatore, M. M., & Capaccione, K. M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05411-4 · Cited by 200
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Cha, S.-R., Jang, J., Park, S., Ryu, S. M., Cho, S.-J., & Yang, S. (2023) · Antioxidants · doi:10.3390/antiox12061210 · Cited by 163
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Yue, Q., Song, Y., Liu, Z., Zhang, L., Yang, L., & Li, J. (2022) · Molecules · doi:10.3390/molecules27154922 · Cited by 130
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Zhai, Y., Wang, T., Fu, Y., Yu, T., Ding, Y. P., & Nie, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098011 · Cited by 112
Metadata
- Authors
- Inui, N., Sakai, S., & Kitagawa, M.
- Affiliations
- Hamamatsu University (JP)
- Corresponding author
- Inui, Naoki
- Kitagawa, Masatoshi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-05
- Volume
- 22
- Issue
- 11
- Pages
- 6107
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8201174
- OpenAlex
- W3169709719
- Cited by
- 169
- References
- 119
- Citations by year
- 2026: 25 · 2025: 52 · 2024: 31 · 2023: 43 · 2022: 14 · 2021: 4
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (20K08539)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, TGF-beta signaling, ubiquitin-proteasome system, epithelial-mesenchymal transition, endothelial-to-mesenchymal transition, E3 ubiquitin ligase, p27 degradation, Skp2, myofibroblast differentiation, extracellular matrix deposition, interstitial lung disease, pirfenidone, nintedanib, fibroblast proliferation
- MeSH terms
- Humans, Pulmonary Fibrosis, Signal Transduction, Transforming Growth Factor beta, Proliferating Cell Nuclear Antigen, Ubiquitin, S-Phase Kinase-Associated Proteins, Proteasome Endopeptidase Complex, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.